{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:52:16Z","timestamp":1758959536219,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00262-021-02909-4","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T13:02:50Z","timestamp":1615640570000},"page":"2951-2960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor immune microenvironment in brain metastases from gynecologic malignancies"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-1948","authenticated-orcid":false,"given":"Corey M.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan R.","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessa","family":"Suhner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Umphlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Zakashansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadejda","family":"Tsankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj K.","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Fowkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Kolev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"2909_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","volume":"150","author":"K Deng","year":"2018","unstructured":"Deng K, Yang C, Tan Q et al (2018) Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol 150:460\u2013465. https:\/\/doi.org\/10.1016\/j.ygyno.2018.06.022","journal-title":"Gynecol Oncol"},{"key":"2909_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/fon-2020-0017","volume":"16","author":"W Mao","year":"2020","unstructured":"Mao W, Wei S, Yang H et al (2020) Clinicopathological study of organ metastasis in endometrial cancer. Future Oncol Lond Engl 16:525\u2013540. https:\/\/doi.org\/10.2217\/fon-2020-0017","journal-title":"Future Oncol Lond Engl"},{"key":"2909_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/gyno.2002.6653","volume":"85","author":"N Anupol","year":"2002","unstructured":"Anupol N, Ghamande S, Odunsi K et al (2002) Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol 85:487\u2013492","journal-title":"Gynecol Oncol"},{"key":"2909_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ygyno.2007.05.027","volume":"107","author":"JC Chura","year":"2007","unstructured":"Chura JC, Marushin R, Boyd A et al (2007) Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review. Gynecol Oncol 107:79\u201385. https:\/\/doi.org\/10.1016\/j.ygyno.2007.05.027","journal-title":"Gynecol Oncol"},{"key":"2909_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ygyno.2016.04.013","volume":"142","author":"S Uccella","year":"2016","unstructured":"Uccella S, Morris JM, Multinu F et al (2016) Primary brain metastases of endometrial cancer: a report of 18 cases and review of the literature. Gynecol Oncol 142:70\u201375. https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.013","journal-title":"Gynecol Oncol"},{"key":"2909_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ygyno.2004.02.006","volume":"93","author":"LT Gien","year":"2004","unstructured":"Gien LT, Kwon JS, D\u2019Souza DP et al (2004) Brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol 93:524\u2013528. https:\/\/doi.org\/10.1016\/j.ygyno.2004.02.006","journal-title":"Gynecol Oncol"},{"key":"2909_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2016.04.030","volume":"142","author":"LM Divine","year":"2016","unstructured":"Divine LM, Kizer NT, Hagemann AR et al (2016) Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain. Gynecol Oncol 142:76\u201382. https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.030","journal-title":"Gynecol Oncol"},{"key":"2909_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10147-019-01556-1","volume":"25","author":"H Yano","year":"2020","unstructured":"Yano H, Nagao S, Yamaguchi S (2020) Leptomeningeal metastases arising from gynecological cancers. Int J Clin Oncol 25:391\u2013395. https:\/\/doi.org\/10.1007\/s10147-019-01556-1","journal-title":"Int J Clin Oncol"},{"key":"2909_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252\u2013264. https:\/\/doi.org\/10.1038\/nrc3239","journal-title":"Nat Rev Cancer"},{"key":"2909_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","volume":"14","author":"SP Patel","year":"2015","unstructured":"Patel SP, Kurzrock R (2015) PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther 14:847\u2013856. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0983","journal-title":"Mol Cancer Ther"},{"key":"2909_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306. https:\/\/doi.org\/10.1038\/nrc3245","journal-title":"Nat Rev Cancer"},{"key":"2909_CR12","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","volume":"20","author":"JM Taube","year":"2014","unstructured":"Taube JM, Klein A, Brahmer JR et al (2014) Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res 20:5064\u20135074. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3271","journal-title":"Clin Cancer Res"},{"key":"2909_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00282","author":"M Lorger","year":"2019","unstructured":"Lorger M, Andreou T, Fife C, James F (2019) Immune checkpoint blockade\u2014how does it work in brain metastases? Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2019.00282","journal-title":"Front Mol Neurosci"},{"key":"2909_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3978\/j.issn.2304-3865.2015.06.03","volume":"4","author":"AS Berghoff","year":"2015","unstructured":"Berghoff AS, Preusser M (2015) The inflammatory microenvironment in brain metastases: potential treatment target? Chin Clin Oncol 4:21. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.06.03","journal-title":"Chin Clin Oncol"},{"key":"2909_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/his.12537","volume":"66","author":"AS Berghoff","year":"2015","unstructured":"Berghoff AS, Ricken G, Widhalm G et al (2015) Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. Histopathology 66:289\u2013299. https:\/\/doi.org\/10.1111\/his.12537","journal-title":"Histopathology"},{"key":"2909_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fimmu.2020.00120","volume":"11","author":"D Herrera-Rios","year":"2020","unstructured":"Herrera-Rios D, Mughal SS, Teuber-Hanselmann S et al (2020) Macrophages\/microglia represent the major source of indolamine 2,3-dioxygenase expression in melanoma metastases of the brain. Front Immunol 11:120. https:\/\/doi.org\/10.3389\/fimmu.2020.00120","journal-title":"Front Immunol"},{"key":"2909_CR17","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/1078-0432.CCR-14-3073","volume":"21","author":"HM Kluger","year":"2015","unstructured":"Kluger HM, Zito CR, Barr ML et al (2015) Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites. Clin Cancer Res Off J Am Assoc Cancer Res 21:3052\u20133060. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3073","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2909_CR18","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","volume":"115","author":"D Taggart","year":"2018","unstructured":"Taggart D, Andreou T, Scott KJ et al (2018) Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking. Proc Natl Acad Sci U S A 115:E1540\u2013E1549. https:\/\/doi.org\/10.1073\/pnas.1714089115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2909_CR19","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.4474","author":"S Batur","year":"2019","unstructured":"Batur S, Dulger O, Durak S et al (2019) Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases. Bosn J Basic Med Sci. https:\/\/doi.org\/10.17305\/bjbms.2019.4474","journal-title":"Bosn J Basic Med Sci"},{"key":"2909_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12885-018-5214-8","volume":"19","author":"R Kim","year":"2019","unstructured":"Kim R, Keam B, Kim S et al (2019) Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors. BMC Cancer 19:19. https:\/\/doi.org\/10.1186\/s12885-018-5214-8","journal-title":"BMC Cancer"},{"key":"2909_CR21","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/annonc\/mdw289","volume":"27","author":"AS Mansfield","year":"2016","unstructured":"Mansfield AS, Aubry MC, Moser JC et al (2016) Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer. Ann Oncol Off J Eur Soc Med Oncol 27:1953\u20131958. https:\/\/doi.org\/10.1093\/annonc\/mdw289","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2909_CR22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2184","author":"K Pocha","year":"2020","unstructured":"Pocha K, Mock A, Rapp C et al (2020) Surfactant expression defines an inflamed subtype of lung adenocarcinoma brain metastases that correlates with prolonged survival. Clin Cancer Res Off J Am Assoc Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2184","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2909_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cllc.2019.05.008","volume":"20","author":"V T\u00e9gl\u00e1si","year":"2019","unstructured":"T\u00e9gl\u00e1si V, Pipek O, L\u00f3zsa R et al (2019) PD-L1 expression of lung cancer cells, unlike infiltrating immune cells, is stable and unaffected by therapy during brain metastasis. Clin Lung Cancer 20:363-369.e2. https:\/\/doi.org\/10.1016\/j.cllc.2019.05.008","journal-title":"Clin Lung Cancer"},{"key":"2909_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/neuonc\/now309","volume":"19","author":"V T\u00e9gl\u00e1si","year":"2017","unstructured":"T\u00e9gl\u00e1si V, Reiniger L, F\u00e1bi\u00e1n K et al (2017) Evaluating the significance of density, localization, and PD-1\/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis. Neuro-Oncol 19:1058\u20131067. https:\/\/doi.org\/10.1093\/neuonc\/now309","journal-title":"Neuro-Oncol"},{"key":"2909_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bbrc.2018.03.053","volume":"498","author":"J Zhou","year":"2018","unstructured":"Zhou J, Gong Z, Jia Q et al (2018) Programmed death ligand 1 expression and CD8+ tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer. Biochem Biophys Res Commun 498:751\u2013757. https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.053","journal-title":"Biochem Biophys Res Commun"},{"key":"2909_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13058-016-0702-8","volume":"18","author":"R Duchnowska","year":"2016","unstructured":"Duchnowska R, P\u0119ksa R, Radecka B et al (2016) Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1\/PD-L axis. Breast Cancer Res BCR 18:43. https:\/\/doi.org\/10.1186\/s13058-016-0702-8","journal-title":"Breast Cancer Res BCR"},{"key":"2909_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.humpath.2013.03.010","volume":"44","author":"A Cimino-Mathews","year":"2013","unstructured":"Cimino-Mathews A, Ye X, Meeker A et al (2013) Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study. Hum Pathol 44:2055\u20132063. https:\/\/doi.org\/10.1016\/j.humpath.2013.03.010","journal-title":"Hum Pathol"},{"key":"2909_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","volume":"32","author":"M Lee","year":"2019","unstructured":"Lee M, Heo S-H, Song IH et al (2019) Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod Pathol 32:70\u201380. https:\/\/doi.org\/10.1038\/s41379-018-0113-8","journal-title":"Mod Pathol"},{"key":"2909_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00262-011-1137-9","volume":"61","author":"Y Liu","year":"2012","unstructured":"Liu Y, Komohara Y, Domenick N et al (2012) Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunol Immunother CII 61:789\u2013801. https:\/\/doi.org\/10.1007\/s00262-011-1137-9","journal-title":"Cancer Immunol Immunother CII"},{"key":"2909_CR30","doi-asserted-by":"publisher","first-page":"103671","DOI":"10.18632\/oncotarget.22110","volume":"8","author":"R Ogiya","year":"2017","unstructured":"Ogiya R, Niikura N, Kumaki N et al (2017) Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer. Oncotarget 8:103671\u2013103681. https:\/\/doi.org\/10.18632\/oncotarget.22110","journal-title":"Oncotarget"},{"key":"2909_CR31","doi-asserted-by":"publisher","first-page":"e1153208","DOI":"10.1080\/2162402X.2016.1153208","volume":"5","author":"B Sobottka","year":"2016","unstructured":"Sobottka B, Pestalozzi B, Fink D et al (2016) Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases. Oncoimmunology 5:e1153208. https:\/\/doi.org\/10.1080\/2162402X.2016.1153208","journal-title":"Oncoimmunology"},{"key":"2909_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s40425-019-0755-1","volume":"7","author":"L Zhu","year":"2019","unstructured":"Zhu L, Narloch JL, Onkar S et al (2019) Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. J Immunother Cancer 7:265. https:\/\/doi.org\/10.1186\/s40425-019-0755-1","journal-title":"J Immunother Cancer"},{"key":"2909_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-016-2216-8","volume":"130","author":"AS Berghoff","year":"2016","unstructured":"Berghoff AS, Ricken G, Wilhelm D et al (2016) Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC). J Neurooncol 130:19\u201329. https:\/\/doi.org\/10.1007\/s11060-016-2216-8","journal-title":"J Neurooncol"},{"key":"2909_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120504","author":"P Roussille","year":"2018","unstructured":"Roussille P, Tachon G, Villalva C et al (2018) Pathological and molecular characteristics of colorectal cancer with brain metastases. Cancers. https:\/\/doi.org\/10.3390\/cancers10120504","journal-title":"Cancers"},{"key":"2909_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/modpathol.2010.234","volume":"24","author":"AM Dahlin","year":"2011","unstructured":"Dahlin AM, Henriksson ML, Van Guelpen B et al (2011) Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. Mod Pathol 24:671\u2013682. https:\/\/doi.org\/10.1038\/modpathol.2010.234","journal-title":"Mod Pathol"},{"key":"2909_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","volume":"119","author":"S Pakneshan","year":"2014","unstructured":"Pakneshan S, Safarpour D, Tavassoli F, Jabbari B (2014) Brain metastasis from ovarian cancer: a systematic review. J Neurooncol 119:1\u20136. https:\/\/doi.org\/10.1007\/s11060-014-1447-9","journal-title":"J Neurooncol"},{"key":"2909_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/gyno.2002.6792","volume":"87","author":"B Pothuri","year":"2002","unstructured":"Pothuri B, Chi DS, Reid T et al (2002) Craniotomy for central nervous system metastases in epithelial ovarian carcinoma. Gynecol Oncol 87:133\u2013137","journal-title":"Gynecol Oncol"},{"key":"2909_CR38","doi-asserted-by":"publisher","first-page":"e1057388","DOI":"10.1080\/2162402X.2015.1057388","volume":"5","author":"AS Berghoff","year":"2016","unstructured":"Berghoff AS, Fuchs E, Ricken G et al (2016) Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology 5:e1057388. https:\/\/doi.org\/10.1080\/2162402X.2015.1057388","journal-title":"Oncoimmunology"},{"key":"2909_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fimmu.2013.00190","volume":"4","author":"DO Adeegbe","year":"2013","unstructured":"Adeegbe DO, Nishikawa H (2013) Natural and induced T regulatory cells in cancer. Front Immunol 4:190. https:\/\/doi.org\/10.3389\/fimmu.2013.00190","journal-title":"Front Immunol"},{"key":"2909_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ygyno.2016.03.008","volume":"141","author":"JR Webb","year":"2016","unstructured":"Webb JR, Milne K, Kroeger DR, Nelson BH (2016) PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer. Gynecol Oncol 141:293\u2013302. https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.008","journal-title":"Gynecol Oncol"},{"key":"2909_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T et al (2017) Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Adv Anat Pathol 24:311\u2013335. https:\/\/doi.org\/10.1097\/PAP.0000000000000161","journal-title":"Adv Anat Pathol"},{"key":"2909_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/2159-8290.CD-13-0310","volume":"3","author":"EA Akbay","year":"2013","unstructured":"Akbay EA, Koyama S, Carretero J et al (2013) Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors. Cancer Discov 3:1355\u20131363. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0310","journal-title":"Cancer Discov"},{"key":"2909_CR43","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos PK, Carter SL, Santagata S et al (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5:1164\u20131177. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0369","journal-title":"Cancer Discov"},{"key":"2909_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2020.1741678","author":"CC Lee","year":"2020","unstructured":"Lee CC, Soon YY, Lum JHY et al (2020) Frequency of discordance in programmed death-ligand 1 (PD-L1) expression between primary tumors and paired distant metastases in advanced cancers: a systematic review and meta-analysis. Acta Oncol. https:\/\/doi.org\/10.1080\/0284186X.2020.1741678","journal-title":"Acta Oncol"},{"key":"2909_CR45","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ygyno.2019.03.004","volume":"153","author":"E Ratner","year":"2019","unstructured":"Ratner E, Bala M, Louie-Gao M et al (2019) Increased risk of brain metastases in ovarian cancer patients with BRCA mutations. Gynecol Oncol 153:568\u2013573. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.004","journal-title":"Gynecol Oncol"},{"key":"2909_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ygyno.2019.05.004","volume":"154","author":"M Stasenko","year":"2019","unstructured":"Stasenko M, Cybulska P, Feit N et al (2019) Brain metastasis in epithelial ovarian cancer by BRCA1\/2 mutation status. Gynecol Oncol 154:144\u2013149. https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.004","journal-title":"Gynecol Oncol"},{"key":"2909_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-017-2459-z","volume":"133","author":"S Balendran","year":"2017","unstructured":"Balendran S, Liebmann-Reindl S, Berghoff AS et al (2017) Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations. J Neurooncol 133:469\u2013476. https:\/\/doi.org\/10.1007\/s11060-017-2459-z","journal-title":"J Neurooncol"},{"key":"2909_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1447-0756.2012.01961.x","volume":"39","author":"M Sekine","year":"2013","unstructured":"Sekine M, Yoshihara K, Komata D et al (2013) Increased incidence of brain metastases in BRCA1-related ovarian cancers. J Obstet Gynaecol Res 39:292\u2013296. https:\/\/doi.org\/10.1111\/j.1447-0756.2012.01961.x","journal-title":"J Obstet Gynaecol Res"},{"key":"2909_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a004341","author":"I Colombo","year":"2019","unstructured":"Colombo I, Garg S, Danesh A et al (2019) Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patient. Cold Spring Harb Mol Case Stud. https:\/\/doi.org\/10.1101\/mcs.a004341","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"2909_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gore.2016.10.004","volume":"18","author":"M Bangham","year":"2016","unstructured":"Bangham M, Goldstein R, Walton H, Ledermann JA (2016) Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease. Gynecol Oncol Rep 18:22\u201324. https:\/\/doi.org\/10.1016\/j.gore.2016.10.004","journal-title":"Gynecol Oncol Rep"},{"key":"2909_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230738","author":"S Gray","year":"2019","unstructured":"Gray S, Khor XY, Yiannakis D (2019) Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2019-230738","journal-title":"BMJ Case Rep"},{"key":"2909_CR52","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270-278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-02909-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-021-02909-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-02909-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T13:06:42Z","timestamp":1631020002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-021-02909-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2909"],"URL":"https:\/\/doi.org\/10.1007\/s00262-021-02909-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"type":"print","value":"0340-7004"},{"type":"electronic","value":"1432-0851"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from Icahn School of Medicine at Mount Sinai. Written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that there are no conflicts of interest or competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}